0000897069-21-000219.txt : 20210510 0000897069-21-000219.hdr.sgml : 20210510 20210510103322 ACCESSION NUMBER: 0000897069-21-000219 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210510 DATE AS OF CHANGE: 20210510 EFFECTIVENESS DATE: 20210510 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Paragon Therapeutics, Inc. CENTRAL INDEX KEY: 0001861055 IRS NUMBER: 862707757 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-398700 FILM NUMBER: 21905613 BUSINESS ADDRESS: STREET 1: C/O FAIRMOUNT FUNDS MANAGEMENT, LLC STREET 2: 2001 MARKET STREET, SUITE 2500 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: (267) 760-4066 MAIL ADDRESS: STREET 1: C/O FAIRMOUNT FUNDS MANAGEMENT, LLC STREET 2: 2001 MARKET STREET, SUITE 2500 CITY: PHILADELPHIA STATE: PA ZIP: 19103 D 1 primary_doc.xml X0708 D LIVE 0001861055 Paragon Therapeutics, Inc. C/O FAIRMOUNT FUNDS MANAGEMENT, LLC 2001 MARKET STREET, SUITE 2500 PHILADELPHIA PA PENNSYLVANIA 19103 (267) 760-4066 DELAWARE None None Corporation true 2021 Evan Thompson c/o Fairmount Funds Management, LLC 2001 Market Street, Suite 2500 Philadelphia PA PENNSYLVANIA 19103 Executive Officer Promoter Peter Harwin Fairmount Funds Management, LLC 2001 Market Street, Suite 2500 Philadelphia PA PENNSYLVANIA 19103 Director Promoter Biotechnology Decline to Disclose 06b false 2021-04-26 false true true false 0 10000000 10000000 0 false 2 0 0 0 false Paragon Therapeutics, Inc. Evan Thompson Evan Thompson President 2021-05-07